A clinical trial assessing a remote weight loss intervention in women with breast cancer saw a reduction in body weight.

New findings demonstrate an association between increased cumulative depression genetic burden and multiple sclerosis (MS) ...

Brensocatib, the first FDA-approved dipeptidyl peptidase 1 (DPP1) inhibitor for non–cystic fibrosis bronchiectasis, may have broader potential for other neutrophil-driven conditions, according to ...

Ravi Vij, MD, MBA, explains how insurance-related delays in CAR T approval slow treatment initiation, increase interim therapy costs, and contribute to patient burden.

Clonally expanded CD8+ T cells appear to play a causal role in the initiation and progression of alopecia areata.

Treatment challenges that Anasuya Gunturi, MD, PhD, encounters in her work at Lowell General Hospital include language ...

“SWIFT-seq is a powerful option as it can measure the number of CTCs, characterize the genomic alterations of the tumor, ...

Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...

Patients with chronic lymphocytic leukemia (CLL) had significantly lower monocyte-to-lymphocyte ratio values compared with ...

A qualitative study found strong support for primary care provider–nephrologist comanagement of chronic kidney disease (CKD), ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and ...